HCA Healthcare, Inc.
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
During January 2025, our Board of Directors authorized a share repurchase program for up to $10 billion of our outstanding common stock. During the quarter ended September 30, 2025, we repurchased 6,514,283 shares of our common stock at an average price of $383.34 per share through market purchases pursuant to the January 2025 authorization. At September 30, 2025, we had $3.256 billion of repurchase authorization available under the January 2025 authorization.
The following table provides certain information with respect to our repurchases of common stock from July 1, 2025 through September 30, 2025 (dollars in billions, except per share amounts).
| Period | Total Numberof SharesPurchased | Average PricePaid per Share | Total Numberof SharesPurchased asPart ofPubliclyAnnouncedPlans orPrograms | ApproximateDollar Value ofShares ThatMay Yet BePurchasedUnder PubliclyAnnounced Plansor Programs |
|---|---|---|---|---|
| July 1, 2025 - July 31, 2025 | 2,175,388 | $363.47 | 2,175,388 | $4.962 |
| August 1, 2025 - August 31, 2025 | 2,545,478 | $383.05 | 2,545,478 | 3.987 |
| September 1, 2025 - September 30, 2025 | 1,793,417 | $407.87 | 1,793,417 | $3.256 |
| Total for third quarter 2025 | 6,514,283 | $383.34 | 6,514,283 |
On October 23, 2025, our Board of Directors declared a quarterly dividend of $0.72 per share on our common stock payable on December 29, 2025 to stockholders of record at the close of business on December 15, 2025. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of our Board of Directors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.